Keurig Dr Pepper, Inc (NASDAQ:KDP - Get Free Report) Director Robert James Gamgort sold 208,000 shares of Keurig Dr Pepper stock in a transaction that occurred on Friday, August 1st. The shares were sold at an average price of $32.90, for a total value of $6,843,200.00. Following the transaction, the director owned 2,292,169 shares of the company's stock, valued at approximately $75,412,360.10. This represents a 8.32% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link.
Robert James Gamgort also recently made the following trade(s):
- On Tuesday, July 29th, Robert James Gamgort sold 208,000 shares of Keurig Dr Pepper stock. The shares were sold at an average price of $33.18, for a total value of $6,901,440.00.
- On Monday, June 2nd, Robert James Gamgort sold 208,000 shares of Keurig Dr Pepper stock. The shares were sold at an average price of $33.10, for a total value of $6,884,800.00.
Keurig Dr Pepper Trading Up 0.1%
Shares of Keurig Dr Pepper stock traded up $0.04 during mid-day trading on Tuesday, hitting $33.32. The stock had a trading volume of 9,630,906 shares, compared to its average volume of 12,252,485. The firm has a 50-day moving average of $33.27 and a two-hundred day moving average of $33.38. The firm has a market cap of $45.26 billion, a P/E ratio of 29.75, a price-to-earnings-growth ratio of 2.43 and a beta of 0.45. The company has a quick ratio of 0.40, a current ratio of 0.64 and a debt-to-equity ratio of 0.56. Keurig Dr Pepper, Inc has a 12-month low of $30.12 and a 12-month high of $38.28.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last posted its earnings results on Thursday, July 24th. The company reported $0.49 EPS for the quarter, meeting analysts' consensus estimates of $0.49. Keurig Dr Pepper had a return on equity of 11.05% and a net margin of 9.75%. The company had revenue of $4.16 billion for the quarter, compared to the consensus estimate of $4.14 billion. During the same quarter in the previous year, the business earned $0.45 earnings per share. The company's revenue for the quarter was up 6.1% on a year-over-year basis. Sell-side analysts forecast that Keurig Dr Pepper, Inc will post 1.92 earnings per share for the current year.
Keurig Dr Pepper Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, July 11th. Shareholders of record on Friday, June 27th were given a $0.23 dividend. The ex-dividend date was Friday, June 27th. This represents a $0.92 dividend on an annualized basis and a yield of 2.8%. Keurig Dr Pepper's payout ratio is currently 82.14%.
Institutional Investors Weigh In On Keurig Dr Pepper
A number of institutional investors and hedge funds have recently added to or reduced their stakes in KDP. Townsquare Capital LLC raised its position in Keurig Dr Pepper by 2.1% in the 4th quarter. Townsquare Capital LLC now owns 15,734 shares of the company's stock valued at $505,000 after purchasing an additional 327 shares in the last quarter. Private Trust Co. NA raised its position in Keurig Dr Pepper by 26.4% in the 2nd quarter. Private Trust Co. NA now owns 1,624 shares of the company's stock valued at $54,000 after purchasing an additional 339 shares in the last quarter. Commerce Bank raised its position in Keurig Dr Pepper by 1.6% in the 1st quarter. Commerce Bank now owns 21,513 shares of the company's stock valued at $736,000 after purchasing an additional 340 shares in the last quarter. First American Bank raised its position in Keurig Dr Pepper by 0.6% in the 1st quarter. First American Bank now owns 59,564 shares of the company's stock valued at $2,038,000 after purchasing an additional 344 shares in the last quarter. Finally, Allworth Financial LP raised its position in Keurig Dr Pepper by 3.8% in the 1st quarter. Allworth Financial LP now owns 10,242 shares of the company's stock valued at $353,000 after purchasing an additional 371 shares in the last quarter. Hedge funds and other institutional investors own 93.99% of the company's stock.
Wall Street Analysts Forecast Growth
KDP has been the topic of several research analyst reports. Piper Sandler raised Keurig Dr Pepper from a "neutral" rating to an "overweight" rating and raised their price objective for the company from $35.00 to $40.00 in a report on Wednesday, April 9th. Royal Bank Of Canada reissued an "outperform" rating and issued a $42.00 price objective on shares of Keurig Dr Pepper in a report on Tuesday, April 22nd. JPMorgan Chase & Co. dropped their price objective on Keurig Dr Pepper from $39.00 to $38.00 and set an "overweight" rating on the stock in a report on Thursday, July 17th. Barclays reaffirmed an "overweight" rating and issued a $39.00 price target (up from $37.00) on shares of Keurig Dr Pepper in a research note on Monday, July 28th. Finally, HSBC raised Keurig Dr Pepper from a "hold" rating to a "buy" rating and lifted their price target for the stock from $36.00 to $42.00 in a research note on Friday, April 25th. Two equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $39.77.
Read Our Latest Stock Analysis on KDP
About Keurig Dr Pepper
(
Get Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.